EXX7 📈 iShares Nikkei 225 UCITS - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: DE000A0H08D2 • Japan Large-Cap Equity
EXX7: Japanese, Stocks, Equities
The iShares Nikkei 225 UCITS ETF (DE), listed on XETRA under the ticker EXX7, is a German-domiciled exchange-traded fund that provides investors with exposure to the Japanese equity market. It tracks the Morningstar Japan TME NR JPY index, which is designed to measure the performance of large-cap Japanese stocks. The fund's ISIN is DE000A0H08D2, and it is classified as a Japan Large-Cap Equity ETF, making it a popular choice for investors seeking to diversify their portfolios with a targeted allocation to Japanese blue-chip companies.
As a UCITS-compliant ETF, the iShares Nikkei 225 UCITS ETF (DE) is subject to strict regulatory requirements, ensuring that it operates in a transparent and investor-friendly manner. The fund's underlying index, the Morningstar Japan TME NR JPY, is a rules-based benchmark that aims to capture the performance of the Japanese large-cap market, providing investors with a broad and diversified exposure to the country's most established companies. With its listing on XETRA, the fund is easily accessible to investors across Europe and beyond, offering a convenient way to gain exposure to the Japanese equity market.
Investors can find more information about the iShares Nikkei 225 UCITS ETF (DE) on the iShares website, which provides detailed information on the fund's investment objective, strategy, and performance. The website, available at http://www.iShares.de, also offers a range of tools and resources to help investors make informed decisions about their investments. By tracking the Morningstar Japan TME NR JPY index, the iShares Nikkei 225 UCITS ETF (DE) aims to provide investors with a reliable and efficient way to tap into the growth potential of the Japanese large-cap equity market, while also benefiting from the advantages of ETF investing, such as flexibility, transparency, and cost-effectiveness.
Additional Sources for EXX7 ETF
EXX7 ETF Overview
Market Cap in USD | 29,670m |
Category | Japan Large-Cap Equity |
IPO / Inception | 2006-07-05 |
EXX7 ETF Ratings
Growth 5y | 37.8% |
Fundamental | - |
Dividend | 19.7% |
Rel. Strength Industry | -20.9 |
Analysts | - |
Fair Price Momentum | 22.85 EUR |
Fair Price DCF | - |
EXX7 Dividends
Dividend Yield 12m | 0.56% |
Yield on Cost 5y | 0.72% |
Annual Growth 5y | -17.40% |
Payout Consistency | 87.1% |
EXX7 Growth Ratios
Growth Correlation 3m | 33.9% |
Growth Correlation 12m | 42.8% |
Growth Correlation 5y | 60.4% |
CAGR 5y | 5.14% |
CAGR/Mean DD 5y | 0.56 |
Sharpe Ratio 12m | 0.52 |
Alpha | -3.78 |
Beta | 0.57 |
Volatility | 14.79% |
Current Volume | 16.9k |
Average Volume 20d | 10.1k |
As of December 21, 2024, the stock is trading at EUR 24.03 with a total of 16,917 shares traded.
Over the past week, the price has changed by -3.61%, over one month by +2.30%, over three months by +1.76% and over the past year by +14.76%.
Partly, yes. Based on ValueRay Analyses, iShares Nikkei 225 UCITS (XETRA:EXX7) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 37.83 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EXX7 as of December 2024 is 22.85. This means that EXX7 is currently overvalued and has a potential downside of -4.91%.
iShares Nikkei 225 UCITS has no consensus analysts rating.
According to ValueRays Forecast Model, EXX7 iShares Nikkei 225 UCITS will be worth about 25.1 in December 2025. The stock is currently trading at 24.03. This means that the stock has a potential upside of +4.33%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.1 | 4.3% |